Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 5/20 | 0.45 |
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL496699 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL497016 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL151083 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL496726 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL437985 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL908021 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL304724 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL1239006 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL22608765 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL150843 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561313-A | Method for synthesizing copper halide-based colloid nanocrystalline at room temperature and application | 浙江大学 | 2024-08-30 | — | — | CN | claimed |
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| EP-0913408-B1 | Process for making poly(alkyl (meth)acrylate) rubber latex | GEN ELECTRIC (US) | 2003-07-23 | — | — | EP | claimed |
| US-5135620-A | Using copper salt of hydrocarbonsulfonic acid as extractant | PHILLIPS PETROLEUM COMPANY (US) | 1992-08-04 | — | — | US | claimed |
| US-20250223383-A1 | Multiple Reactor and Multiple Zone Polyolefin Polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-07-10 | — | — | US | disclosed |
| WO-2025084274-A1 | METHOD FOR DISSOLVING SPARINGLY WATER-SOLUBLE PROTEIN, PROTEIN SOLUTION OBTAINED BY SAID METHOD, AND MOLDED BODY OF SAID SOLUTION | 株式会社ファーマフーズ | 2025-04-24 | — | — | WO | disclosed |
| CN-119775513-A | Temperature-resistant salt-resistant thickening agent for fracturing and preparation method thereof | 中国石油天然气集团有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-12252558-B2 | Multiple reactor and multiple zone polyolefin polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-18 | — | — | US | disclosed |
| US-12157162-B2 | Additive for forming sand mold, sand composition for forming sand mold, method for producing sand mold, and sand mold | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 2024-12-03 | — | — | US | disclosed |
| CN-118561313-A | Method for synthesizing copper halide-based colloid nanocrystalline at room temperature and application | 浙江大学 | 2024-08-30 | — | — | CN | disclosed |
| US-4048118-A | ALKALI METAL SALT OF ORGANIC ACID, AMINE SALT OF PHYTIC ACID | SHOWA DENKO K.K. (JA) | 1977-09-13 | — | — | US | disclosed |
| US-4046906-A | FUNGICIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-09-06 | — | — | US | disclosed |
| US-4042669-A | ABSORPTION, INERT DILUENT, COPPER ORGANIC SALT | PHILLIPS PETROLEUM COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-4025574-A | UNSATURATED ALIPHATICS FROM SATURATED ALIPHATICS BY COMPLEXING WITH COPPER ALKYLBENZENESULFONATE | PHILLIPS PETROLEUM COMPANY (US) | 1977-05-24 | — | — | US | disclosed |
| US-4011058-A | PRODUCTION OF SUBSTITUTE NATURAL GAS FROM GASIFICATION OF COAL CHAR | PHILLIPS PETROLEUM COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3956252-A | BASIC NITROGEN-CONTAINING SALT OF PHYTIC ACID | SHOWA DENKU K.K. (JA) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | FAAH 4/4885EPHX2 1062/4885CA2 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.